Retinoids and their receptors in cancer development and chemoprevention

Area of Science:

• Oncology
• Molecular Biology
• Nutritional Science

Background:

• Retinoids regulate normal, premalignant, and malignant cell growth, particularly epithelial cells.
• Interaction with retinoic acid receptors (RARs) and retinoid X receptors (RXRs) mediates retinoid functions.
• Vitamin A deficiency and aberrant retinoid receptor expression are linked to increased cancer risk and incidence.

Purpose of the Study:

• To investigate the role of retinoids in cancer development and prevention.
• To explore the molecular mechanisms of retinoid signaling in carcinogenesis.
• To evaluate the potential of retinoids in chemoprevention and treatment of epithelial malignancies.

Main Methods:

• Analysis of retinoid signaling pathways and nuclear receptor interactions.
• Studies on vitamin A deficiency in animal models to assess cancer susceptibility.
• Epidemiological data analysis correlating dietary vitamin A intake with cancer risk.
• In vitro cell transformation assays and in vivo animal carcinogenesis models.
• Clinical studies on retinoid therapy for premalignant lesions and secondary tumor prevention.

Main Results:

• Aberrant retinoid receptor expression and function are early events in carcinogenesis.
• Vitamin A deficiency increases susceptibility to chemical carcinogens and cancer incidence.
• Retinoids at pharmacological doses suppress cell transformation and inhibit carcinogenesis in animal models.
• Retinoids reduce premalignant human epithelial lesions and prevent second primary tumors in various cancers.

Conclusions:

• Retinoid signaling plays a critical role in cancer development and prevention.
• Disruptions in retinoid signaling are implicated as early events in carcinogenesis.
• Pharmacological doses of retinoids demonstrate significant potential for cancer chemoprevention and reducing secondary tumor formation.